Telix Pharmaceuticals
Telix Pharmaceuticals develops radiopharmaceuticals, cancer-targeting drugs that pair a radioactive atom with a molecule guiding it to tumours, so it sits in the peptide platform layer of the metabolic pool.
Checked against the company's own business description in its latest annual filing.
Latest disclosed
20-F filed 2026-02-20 · period ending 2025-12-31
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.